![Ronald Stafford Watts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ronald Stafford Watts
Direktor/Vorstandsmitglied bei Wenkart Foundation
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Murray Bleach | M | - | 12 Jahre | |
Andrew Walton-Green | M | 61 |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | 10 Jahre |
Paul Francis Meehan | M | - | 21 Jahre | |
Michael Lovett | M | - |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | - |
Jon Collins | M | - |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Valerie Jean Duncan | F | - | 13 Jahre | |
Michael Fahey | M | - | 5 Jahre | |
Nathan Cain Francis | M | - | 2 Jahre | |
Nitin Singhi | M | - | 6 Jahre | |
Rebecca Tucker | F | - | - | |
Edward James Hanna | M | - | - | |
Tracy Bucciarelli | F | - | 7 Jahre | |
John MacKay | M | 72 | 2 Jahre | |
Stephen Treadway Twaddell | M | - | 12 Jahre | |
Barry Wayne Denton | M | - | 16 Jahre | |
William James Moss | M | - | 2 Jahre | |
Ivan Roman Slavich | M | 59 | - | |
Jey Jeyasothy | M | - | - | |
Troy Davis | M | - | - | |
Mark de Kock | M | 57 | 5 Jahre | |
Anna Sandham | F | - | 2 Jahre | |
Scott Wooldridge | M | - | 3 Jahre | |
Paul Cooper | M | - | - | |
Philip Geoffrey Randall | M | - | - | |
Carolyn West | F | - | 3 Jahre | |
Helge Sangkuhl | M | - | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Australien | 23 | 88,46% |
Vereinigtes Königreich | 3 | 11,54% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Ronald Stafford Watts
- Persönliches Netzwerk